Skip to content
2000
Volume 3, Issue 5
  • ISSN: 1570-1808
  • E-ISSN: 1875-628X

Abstract

In the article entitled "Pyrazinobenzodiazepines as Potent Nonpeptide Vasopressin Receptor Antagonists" by Jay M. Matthews et al. (Letters in Drug Design & Discovery, 2005, Vol. 2(3), 219-223) the authors report that for the Page 222, column 1, paragraph 3, line 9: The reduction of urine osmolality should be 77% (not 23%). Page 222, column 2, line 3: The alteration of urine osmolality should be -81% (not -19%).

Loading

Article metrics loading...

/content/journals/lddd/10.2174/157018006777574186
2006-07-01
2025-11-02
Loading full text...

Full text loading...

/content/journals/lddd/10.2174/157018006777574186
Loading

  • Article Type:
    Research Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test